The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative
新型 ETA 受体拮抗剂 HJP-272 与青蒿素衍生物联合使用可预防脑疟疾脑微血管出血并协同提高生存率
期刊:Life Sciences
影响因子:5.2
doi:10.1016/j.lfs.2012.07.006
Minxian Dai, Brandi Freeman, Fernando P Bruno, Henry J Shikani, Herbert B Tanowitz, Louis M Weiss, Sandra E Reznik, Ralph A Stephani, Mahalia S Desruisseaux
